Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Edivoxetine

Base Information Edit
  • Chemical Name:Edivoxetine
  • CAS No.:1194508-25-2
  • Molecular Formula:C18H26FNO4
  • Molecular Weight:339.4
  • Hs Code.:
  • UNII:3W9N3F4JOO
  • DSSTox Substance ID:DTXSID70152464
  • Wikipedia:Edivoxetine
  • Wikidata:Q3047670
  • NCI Thesaurus Code:C166706
  • Metabolomics Workbench ID:152219
  • ChEMBL ID:CHEMBL2103857
  • Mol file:1194508-25-2.mol
Edivoxetine

Synonyms:alpha-((5-fluoro-2-methoxyphenyl)methyl)-alpha-(tetrahydro-2H-pyran-4-yl)-2-morpholinemethanol;edivoxetine;LY 2216684;LY-2216684;LY2216684

Suppliers and Price of Edivoxetine
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • Crysdot
  • (R)-2-(5-Fluoro-2-methoxyphenyl)-1-((S)-morpholin-2-yl)-1-(tetrahydro-2H-pyran-4-yl)ethanol 95+%
  • 1g
  • $ 1550.00
Total 4 raw suppliers
Chemical Property of Edivoxetine Edit
Chemical Property:
  • Boiling Point:484.3±40.0 °C(Predicted) 
  • PKA:13.62±0.29(Predicted) 
  • PSA:59.95000 
  • Density:1.198±0.06 g/cm3(Predicted) 
  • LogP:1.85170 
  • XLogP3:1.3
  • Hydrogen Bond Donor Count:2
  • Hydrogen Bond Acceptor Count:6
  • Rotatable Bond Count:5
  • Exact Mass:339.18458647
  • Heavy Atom Count:24
  • Complexity:393
Purity/Quality:

95% *data from raw suppliers

(R)-2-(5-Fluoro-2-methoxyphenyl)-1-((S)-morpholin-2-yl)-1-(tetrahydro-2H-pyran-4-yl)ethanol 95+% *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:

SDS file from LookChem

Useful:
  • Canonical SMILES:COC1=C(C=C(C=C1)F)CC(C2CCOCC2)(C3CNCCO3)O
  • Isomeric SMILES:COC1=C(C=C(C=C1)F)C[C@]([C@@H]2CNCCO2)(C3CCOCC3)O
  • Recent ClinicalTrials:A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
  • Recent EU Clinical Trials:LY2216684 compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Post RFQ for Price